Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aditxt Inc (NQ: ADTX )

0.3700 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EST, Dec 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aditxt Inc

< Previous 1 2 3 4 5 6 7 8 Next >
The US Reaches One Million Organ Transplants
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Pricing of Public Offering
Via Investor Brand Network
Aditxt Announces Pricing of $20.0 Million Public Offering
From Aditxt
Via Business Wire
Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022
From Aditxt, Inc.
Via Business Wire
Researchers Believe Seasonal Allergies Are Worsening
Via Investor Brand Network
Researchers Find Link Between Steroidal Allergy Treatments, Decreased Brain Function
Via Investor Brand Network
Study Finds Children Have Better Outcomes with Kidney Transplants from Living Donors
Via Investor Brand Network
Study Finds That Early Exposure to Antibiotics May Trigger Asthma, Permanent Allergies
Via Investor Brand Network
Senate Review Reveals Screening Mistakes Caused Organ Transplant Failures, Illnesses, Deaths
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses
Via Investor Brand Network
Combining Immunotherapy with Anti-Rejection Drugs Can Treat Cancer, Prevent Kidney Transplant Rejection
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Bell2Bell Podcast
Via Investor Brand Network
Exposures COVID-19
Aditxt Inc. (NASDAQ: ADTX) Seeks to Address Variability of Immune Responses
Via Investor Brand Network
Study Finds That Introducing Some Foods to Infants Early Reduces Risks of Allergies
Via Investor Brand Network
Study Highlights New Insights on Neurological Autoimmune Illnesses
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Equipping Physicians, Individuals with Comprehensive Immune System Views
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Moves One Step Closer to In-Human Trials with Completion of Preclinical Toxicity Study
Via Investor Brand Network
Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100 Advancing it Closer to First-in-Human Trials
From Aditxt, Inc.
Via Business Wire
Virtual Biopsies May Revolutionize Procedures Used in Heart Transplants
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Pursuing Strategy Against COVID-19, Immune System-Related Maladies
Via Investor Brand Network
Exposures COVID-19
Hope of Herd Immunity Dwindles Alongside Federal COVID-19 Budget and Supplies; Aditxt Inc. (NASDAQ: ADTX) and AditxtScore(TM) Could Create Map to COVID-19 Immune Responses
Via Investor Brand Network
Exposures COVID-19
Uncertainty Causes Patients with Systemic Autoimmune Conditions to Be Depressed
Via Investor Brand Network
New Breakthrough Suggests a Liver Can Survive for Days Before Transplantation
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Added to PMLS Menu of Testing Services
Via Investor Brand Network
Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Platform Provides Consumers and Physicians with Data Needed to Make Informed Health Decisions on COVID-19
Via Investor Brand Network
Exposures COVID-19
New Spike in COVID Infections, 1M+ Death Toll, Underscore Potential Value of Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Technologies
Via Investor Brand Network
Topics Death
Exposures COVID-19 Death
Study Says Some Allergies Lower Covid Infection Risk
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Engages IBN for Corporate Communications Expertise
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Platform ‘Is the Right Technology at the Right Time’
Via Investor Brand Network
Exposures COVID-19
Study Discovers Gene Defect That Causes Allergies, Autoimmune Illnesses
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.